Table 3

Survival of patients in the Leicester series compared with the EORTC series when classified by prognostic group

GroupNo. of patientsMedian survival (months)One year survival (%)Two year survival (%)
LeicesterEORTCLeicesterEORTCLeicesterEORTCLeicesterEORTC
Low risk491059.410.840.6409.914
95% CI5.9 to 12.925.6 to 55.730 to 500 to 21.3 6 to 22
High risk75763.85.514.1123.50
95% CI3.2 to 4.46.0 to 22.24 to 200 to 9.2